Skip to Content

IRBESARTAN 300 MG FILM-COATED TABLET

Active substance(s): IRBESARTAN

View full screen / Print PDF » Download PDF ⇩
Transcript
Package leaflet: Information for the user
Irbesartan 75 mg film-coated tablets
Irbesartan 150 mg film-coated tablets
Irbesartan 300 mg film-coated tablets
Irbesartan

Read all of this leaflet carefully before you start taking this medicine because it contains
important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor, or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm
them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible
side effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Irbesartan is and what it is used for
2. What you need to know before you take Irbesartan
3. How to take Irbesartan
4. Possible side effects
5. How to store Irbesartan
6. Contents of the pack and other information

1.

What Irbesartan is and what it is used for

Irbesartan belongs to a group of medicines known as angiotensin-II receptor antagonists.
Angiotensin-II is a substance produced in the body which binds to receptors in blood vessels
causing them to tighten. This results in an increase in blood pressure. Irbesartan prevents the
binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood
pressure to lower. Irbesartan slows the decrease of kidney function in patients with high blood
pressure and type 2 diabetes.
Irbesartan is used in adult patients
 to treat high blood pressure (essential hypertension)
 to protect the kidney in patients with high blood pressure, type 2 diabetes and laboratory
evidence of impaired kidney function.

2.

What you need to know before you take Irbesartan

Do not take Irbesartan
 if you are allergic (hypersensitive) to irbesartan or any of the other ingredients of this
medicine (listed in section 6).
 if you are more than 3 months pregnant. (It is also better to avoid Irbesartan in early
Page 1



pregnancy – see pregnancy section)
if you have diabetes mellitus or impaired kidney function and you are treated with a
blood pressure lowering medicine containing aliskiren..

Warnings and precautions
Talk to your doctor or pharmacist before taking Irbesartan:
 if you get excessive vomiting or diarrhoea
 if you suffer from kidney problems
 if you suffer from heart problems
 if you receive Irbesartan for diabetic kidney disease. In this case your doctor may
perform regular blood tests, especially for measuring blood potassium levels in case of
poor kidney function
 if you are going to have an operation (surgery) or be given anaesthetics
 if you are taking any of the following medicines used to treat high blood pressure:
 an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have
diabetes-related kidney problems.
 aliskiren.
Your doctor may check your kidney function, blood pressure, and the amount of electrolytes
(e.g. potassium) in your blood at regular intervals.
See also information under the heading “Do not take Irbesartan”.
You must tell your doctor if you think you are (or might become) pregnant. Irbesartan is not
recommended in early pregnancy, and must not be taken if you are more than 3 months
pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy
section).
Children and adolescents
This medicinal product should not be used in children and adolescents because the safety and
efficacy have not yet been fully established.
Other medicines and Irbesartan
Tell your doctor or pharmacist if you are taking or have recently taken or might take any other
medicines.
Your doctor may need to change your dose and/or to take other precautions:
If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do
not take Irbesartan” and “Warnings and precautions”).
You may need to have blood checks if you take:
 potassium supplements
 salt substitutes containing potassium
 potassium-sparing medicines (such as certain diuretics)
 medicines containing lithium.
If you take certain painkillers, called non-steroidal anti-inflammatory drugs, the effect of
irbesartan may be reduced.
Page 2

Irbesartan with food and drink
Irbesartan HEC can be taken with or without food.
Pregnancy and breast-feeding
Pregnancy
You must tell your doctor if you think you are (or might become) pregnant. Your doctor will
normally advise you to stop taking Irbesartan before you become pregnant or as soon as you
know you are pregnant and will advise you to take another medicine instead of Irbesartan.
Irbesartan is not recommended in early pregnancy, and must not be taken when more than 3
months pregnant, as it may cause serious harm to your baby if used after the third month of
pregnancy.
Breast-feeding
Tell your doctor if you are breast-feeding or about to start breast-feeding. Irbesartan is not
recommended for mothers who are breast-feeding, and your doctor may choose another
treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born
prematurely.
Driving and using machines
No studies on the effects on the ability to drive and use machines have been performed.
Irbesartan HEC is unlikely to affect your ability to drive or use machines. However,
occasionally dizziness or weariness may occur during treatment of high blood pressure. If you
experience these, talk to your doctor before attempting to drive or use machines.
Irbesartan contains lactose.
If you have been told by your doctor that you have an intolerance to some sugars (e.g. lactose),
contact your doctor before taking this medicine.

3.

How to take Irbesartan tablets

Always take this medicine exactly as your doctor has told you. Check with your doctor
or pharmacist if you are not sure.
Method of administration
Irbesartan is for oral use. Swallow the tablets with a sufficient amount of fluid (e.g. one glass
of water). You can take Irbesartan with or without food. Try to take your daily dose at about
the same time each day. It is important that you continue to take Irbesartan until your doctor
tells you otherwise.


Patients with high blood pressure
The usual dose is 150 mg once a day. The dose may later be increased to 300 mg once
daily depending on blood pressure response.



Patients with high blood pressure and type 2 diabetes with kidney disease
In patients with high blood pressure and type 2 diabetes, 300 mg once daily is the
preferred maintenance dose for the treatment of associated kidney disease.

Page 3

The doctor may advise a lower dose, especially when starting treatment in certain patients
such as those on haemodialysis, or those over the age of 75 years.
The maximal blood pressure lowering effect should be reached 4-6 weeks after beginning
treatment.

Use in Children and adolescents
Irbesartan should not be given to children under 18 years of age. If a child swallows some
tablets, contact your doctor immediately.
If you take more Irbesartan than you should
If you accidentally take too many tablets, contact your doctor immediately.
If you forget to take Irbesartan tablets
If you accidentally miss a daily dose, just take the next dose as normal. Do not take a double
dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some of these effects may be serious and may require medical attention.
As with similar medicines, rare cases of allergic skin reactions (rash, urticaria), as well as
localized swelling of the face, lips and/or tongue have been reported in patients taking
irbesartan. If you get any of these symptoms or get short of breath, stop taking Irbesartan
and contact your doctor immediately.
Side effects reported in clinical studies for patients treated with Irbesartan were:
 Very common (may affect more than 1 in 10 people): if you suffer from high blood
pressure and type 2 diabetes with kidney disease, blood tests may show an increased level
of potassium.
 Common (may affect up to 1 in 10 people): dizziness, feeling sick/vomiting, fatigue and
blood tests may show raised levels of an enzyme that measures the muscle and heart
function (creatine kinase enzyme). In patients with high blood pressure and type 2
diabetes with kidney disease, dizziness when getting up from a lying or sitting position,
low blood pressure when getting up from a lying or sitting position, pain in joints or
muscles and decreased levels of a protein in the red blood cells (haemoglobin) were also
reported.
 Uncommon (may affect up to 1 in 100 people): heart rate increased, flushing, cough,
diarrhoea, indigestion/heartburn, sexual dysfunction (problems with sexual performance),
chest pain.
 Not known (frequency cannot be estimated from the available data): feeling of spinning,
Page 4

headache, taste disturbance, ringing in the ears, muscle cramps, pain in joints and muscles,
abnormal liver function, increased blood potassium levels, impaired kidney function, and
inflammation of small blood vessels mainly affecting the skin (a condition known as
leukocytoclastic vasculitis). Uncommon cases of jaundice (yellowing of the skin and/or
whites of the eyes) have also been reported.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet. You can also report side effects directly via thethe Yellow
Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide
more information on the safety of this medicine. By reporting side effects you can help provide
more information on the safety of this medicine.

5.

How to store Irbesartan

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister or carton after
“EXP”. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist
how to throw away medicines you no longer use. These measures will help protect the
environment.

6.

Contents of the pack and other information

What Irbesartan tablets contains
 The active substance is irbesartan. Each film-coated tablet contains 75 mg, 150 mg or 300
mg irbesartan.
 The other ingredients are microcrystalline cellulose, lactose monohydrate, croscarmellose
sodium, colloidal anhydrous silica, hypromellose, magnesium stearate, and film-coating
material Opadry II 85F48105 containing: polyvinyl alcohol-part hydrolyzed, titanium
dioxide (E171), talc and macrogol 3350.
What Irbesartan looks like and contents of the pack
Irbesartan 75 mg tablets are white or almost white capsular shaped film-coated tablets,
debossed "S63" on one side and blank on the other.
Irbesartan 150 mg tablets are white or almost white capsular shaped film-coated tablets,
debossed "S62" on one side and blank on the other.
Irbesartan 300 mg tablets are white or almost white capsular shaped film-coated tablets,
debossed "S61" on one side and blank on the other.
Pack size:
14, 28, 30, 56, 60, 98 and 120 tablets in PVC/PVDC/ALU blister
Not all pack sizes may be marketed.
Page 5

Marketing Authorisation Holder
HEC Pharm GmbH
Gabriele-Tergit-Promenade 17, 10963 Berlin,
Germany
Tel: +49 30 33007721
Fax: +49 30 33007723
E-Mail: info@hecpharm.biz
Manufacturer
Formula Pharmazeutische und chemische Entwicklungs GmbH
Goerzallee 305b, D-14167 Berlin,
Germany
This medicinal product is authorised in the Member States of the EEA under the
following names:
Germany

United Kingdom

Irbesartan HEC Pharm 75 mg Filmtabletten
Irbesartan HEC Pharm 150 mg Filmtabletten
Irbesartan HEC Pharm 300 mg Filmtabletten
Irbesartan 75 mg Film-coated Tablet
Irbesartan 150 mg Film-coated Tablet
Irbesartan 300 mg Film-coated Tablet

This leaflet was last revised in 03/2016.

Page 6

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide